Cheng Liao

485 citations
12 papers · 268 indexed · h-index 5
Topics
Monoclonal and Polyclonal Antibodies Research (6 papers)Mast cells and histamine (3 papers)Chronic Lymphocytic Leukemia Research (3 papers)
Partner nations
ChinaUnited States

In The Last Decade

Cheng Liao

10 papers receiving 258 citations

Peers

Cheng Liao
Comparison fields: 5 of 45
  • Immunology 131
  • Genetics 127
  • Molecular Biology 75
  • Radiology, Nuclear Medicine and Imaging 61
  • Pathology and Forensic Medicine 60
Replace Katalin Csermak with:
Katalin Csermak Switzerland
Edwin de Zwart United States
Bart van Lith United States
Eugenio Lucia Italy
M. Georget France
Elizabeth Kieras United States
Abbarna A. Cumaraswamy Canada
Toshie Ogasawara Japan
Anna Orlova Austria
Smit Shah United States
Cheng Liao relative to Katalin Csermak Switzerland Katalin Csermak's profile →
Citations per field
00.5×
Katalin Csermak · 1×
Citations per year

Countries citing papers authored by Cheng Liao

Since Specialization
Citations

This map shows the geographic impact of Cheng Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng Liao more than expected).

Fields of papers citing papers by Cheng Liao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng Liao. The network helps show where Cheng Liao may publish in the future.

Co-authorship network of co-authors of Cheng Liao

This figure shows the co-authorship network connecting the top 25 collaborators of Cheng Liao. A scholar is included among the top collaborators of Cheng Liao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng Liao. Cheng Liao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1 2
2 0
3 0
4 2
5 3
6 2
7 2
8 50
9 35
10 105
11 28
12 39

About Cheng Liao

Cheng Liao is a scholar working on Immunology, Genetics and Radiology, Nuclear Medicine and Imaging, having authored 12 papers that have together received 268 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (6 papers), Mast cells and histamine (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). The work is most often cited by research in Genetics (127 citations), Immunology (131 citations) and Hematology (59 citations). Cheng Liao has collaborated with scholars based in China and United States. Frequent co-authors include Julie A. DeMartino, Seng‐Lai Tan, Matthew C. Lucas, Satwant K. Narula, Christopher S. Stevenson, Dong‐Qing Hu, Achal Pashine, Daigen Xu, John Woods and Jay S. Fine. Their work appears in journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Pharmacology & Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026